Danaher (DHR) stock trades ~5% lower as the company, with its Q4 2024 results, projects a sales contraction in the current ...
Danaher's Q4 earnings missed expectations due to a decline in its diagnostics segment, despite stronger sales in ...
TD Cowen made an adjustment to Danaher Corporation's (NYSE:DHR) financial outlook by reducing the price target from $315.00 to $260.00. Despite this change, the firm has maintained a Buy rating on the ...
Stifel analysts reduced the price target for Danaher Corporation shares (NYSE:DHR) to $260 from the previous target of $265, while maintaining a Hold rating on the stock. The new target sits within ...
The stock of Danaher (DHR) is down about 10% after the medical device maker reported mixed results for the fourth quarter of ...
Danaher Corporation DHR reported weaker-than-expected fourth-quarter earnings on Wednesday. The company reported fourth-quarter adjusted earnings per share of $2.14 missing the street view of $2.16.
TD Cowen analyst Dan Brennan lowered the firm’s price target on Danaher (DHR) to $260 from $315 and keeps a Buy rating on the shares. The firm ...
This positive outcome has rippled through the industry, with Danaher and Thermo Fisher anticipating their own earnings reports later this week. Analysts have weighed in on Sartorius's results, ...
In this article, we are going to take a look at where Danaher Corporation (NYSE:DHR) stands against the other diversified dividend stocks. In this article, we will take a look at some of the best ...
U.S. stocks slipped after the Federal Reserve held its main interest rate steady and broke a run of cuts that began in ...
Beckman Coulter Diagnostics, a global leader in advanced diagnostics, today announced availability of new Research Use Only (RUO) blood-based biomarker immunoassays designed to advance ...